Greenwich LifeSciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
GLSI Nasdaq 2836 greenwichlifesciences.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Greenwich LifeSciences, Inc.

Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing - May 22nd, 2026 2:30 pm
Greenwich LifeSciences Provides Update Regarding Form 10-K Filing - Apr 30th, 2026 4:00 am
Greenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026 - Apr 23rd, 2026 4:00 am
Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026 - Apr 20th, 2026 4:00 am
Greenwich LifeSciences Provides Update on Financing Strategy - Apr 14th, 2026 4:00 am
Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential - Apr 7th, 2026 4:00 am
Greenwich LifeSciences Announces Addition of City of Hope to FLAMINGO-01 - Mar 19th, 2026 4:00 am
Greenwich LifeSciences Provides Update on Upcoming AACR Meeting - Mar 18th, 2026 4:00 am
Greenwich LifeSciences Provides Update Showing Continued Reduction in Recurrence Rate in the Open Label Arm of FLAMINGO-01 - Mar 17th, 2026 4:00 am
Greenwich LifeSciences Announces Use of Commercially Manufactured GP2 in FLAMINGO-01 - Mar 16th, 2026 4:00 am
Greenwich LifeSciences Provides Update on Increased Patient Screen Rate in FLAMINGO-01 - Mar 3rd, 2026 4:00 am
Greenwich LifeSciences Announces Acceptance of Two Abstracts at AACR Annual Meeting 2026 - Feb 24th, 2026 4:00 am
Greenwich LifeSciences Provides Update on FLAMINGO-01 Cash Burn Rate and Financing Strategy - Jan 27th, 2026 4:00 am
Insiders of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) must be frustrated after market cap dropped US$50m since recent purchases - Jan 23rd, 2026 7:35 am
Sector Update: Health Care Stocks Mixed Late Afternoon - Jan 22nd, 2026 1:54 pm
Top Midday Gainers - Jan 22nd, 2026 11:58 am
Wall Street Set to Open Higher Thursday as Investors Parse GDP, Unemployment Data, Look Ahead to Inflation Report - Jan 22nd, 2026 7:25 am
Investors Await Raft of Key Economic Data as US Futures Rise Thursday Pre-Bell - Jan 22nd, 2026 6:13 am
Greenwich LifeSciences Gets FDA Approval for GP2 for Breast Cancer Recurrence Trial - Jan 22nd, 2026 4:59 am
Greenwich LifeSciences Announces FDA Approves Use of Commercially Manufactured GP2 in FLAMINGO-01 - Jan 22nd, 2026 4:00 am